logo
Current status of immunosuppressive minimization and tolerance strategies
The need for minimization strategies: current problems of immunosuppression
Immunological risks of minimization strategies
The use of novel diagnostics to individualize immunosuppression following transplantation
Immunosuppressive minimization with mTOR inhibitors and belatacept
Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation
Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes
Improvements in Dutch heart transplant patient outcomes: lessons for the future
Improved long-term survival in Dutch heart transplant patients despite increasing donor age: the Rotterdam experience
Pancreas–Kidney transplantation: Impact of dialysis modality on the outcome
Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation
Expanded criteria donor kidneys for retransplantation United Network for Organ Sharing update: proceed with caution
Eculizumab for aHUS post-transplantation: when and how to stop a good thing
Severe small bowel pneumatosis in adult heart transplant recipient
Successful renal transplantation in a patient with a Wiskott–Aldrich syndrome protein ( WASP ) gene mutation